Rising capital expenditures and rising turnover rates are driving the adoption of deep learning techniques to speed up the drug discovery process. The early-stage diagnostic capabilities of such technologies have also emerged as a key driver for their adoption.
Roots Analysis is pleased to announce the publication of its latest research titled “Deep Learning in Drug Discovery and Deep Learning in the Diagnostics Market (2nd Edition), 2023-2035”.
This report features an extensive study of the current market status and potential of the Deep Learning Solutions market in the healthcare sector. This report highlights the efforts of multiple parties involved in this rapidly emerging sector of the pharmaceutical industry. The report includes, among other things:
Executive summary of insights gained during our research. It provides a high-level view of the current state of the deep learning market for drug discovery and diagnostics and its expected evolution in the medium to long term.
An overview of the big data revolution in the healthcare industry and information on artificial intelligence, machine learning and deep learning algorithms.
An in-depth assessment of the market situation of 70+ companies providing deep learning technologies/services for drug discovery based on several relevant parameters.
An in-depth assessment of the market situation of over 130 companies providing diagnostic deep learning technologies/services based on several relevant parameters.
Detailed profiles of key companies developing and servicing technologies related to deep learning, especially drug discovery and diagnostics.
A qualitative analysis highlighting five prevalent competitive forces in the deep learning space.
Analysis of completed and ongoing clinical trials related to deep learning based on several relevant parameters.
An in-depth analysis of the various investments made by the players involved in this sector over the period 2019-2022, based on several relevant parameters.
Analysis of start-ups/small companies (established since 2015, less than 50 employees) in the deep learning market focused on drug discovery and diagnostics.
Refined valuation analysis of companies involved in deep learning in the drug discovery and diagnostics market based on proprietary multivariable dependent valuation models to estimate the current valuation/net worth of industry players.
Detailed market forecasts featuring analysis of current and projected future opportunities across key market segments (listed below)
Therapeutic area
Oncological diseases
Infectious diseases
Neurological disorders
Immune diseases
Endocrine disorders
Cardiovascular disorders
Respiratory diseases
Eye disease
Musculoskeletal disorders
Other diseases
Major geographical regions
North America
Europe
Asia Pacific
rest of the world
Main companies and organizations covered by the report
Edicare
iForia Technologies
Ardigen
Berg
Google
Huawei
Meratib
Inference
NVIDIA
Orkin
Phenomic AI
Pixel AI
Click the link to view the details of this report
https://www.rootsanalysis.com/reports/view_document/deep-learning-in-drug-discovery-market/156.html
You may also be interested in the following titles:
Lipid nanoparticles in drug delivery
A New Cell Cytometer: The Needs of the Times
Global Gene Switch Market
Roots Analysis Consulting – Preferred research partner for global companies
About roots analysis
Roots Analysis is a global leader in pharmaceutical/biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for over 10 years, we bring our advanced analytics/data-driven perspectives to the hands of over 450,000 industry professionals. serving a network of senior stakeholders. To get reliable market insights.
contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#Deep learning for drug discovery market #Deep learning for drug discovery market #Machine learning technology #Deep learning algorithm #Deep learning technology
